Cytokinetics (CYTK) Change in Account Payables (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Change in Account Payables of $1.5 million for Q1 2026, up 133.19% year-over-year from $651386.4 in Q1 2025, and up 591.59% quarter-over-quarter from -$309000.0 in Q4 2025.
Cytokinetics (CYTK) Change in Account Payables (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Change in Account Payables for 17 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 133.19% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $8.8 million (up 609.15% YoY), while the FY2025 annual figure was $2.7 million, up 159.4% from the prior year.
- Change in Account Payables rose to $1.5 million in Q1 2026 per CYTK's latest filing, from -$309000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $13.0 million in Q4 2022 and bottomed at -$10.3 million in Q1 2024.
- Historically, Change in Account Payables has averaged $43529.4 across 5 years, with a median of $950000.0 in 2025.
- On a YoY basis, Change in Account Payables climbed as much as 907.11% in 2022 and fell as far as 630.89% in 2022.
- Cytokinetics' Change in Account Payables stood at $13.0 million in 2022, then slumped by 40.9% to $7.7 million in 2023, then retreated by 23.42% to $5.9 million in 2024, then plunged by 105.23% to -$309000.0 in 2025, then surged by 591.59% to $1.5 million in 2026.
- Business Quant data shows CYTK's Change in Account Payables at $1.5 million in Q1 2026, -$309000.0 in Q4 2025, and $6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30,000.00 |
| Jun 30, 2026 | 30,000.00 |
| Mar 31, 2026 | 1.52 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | -309,000.00 |
| Dec 31, 2025 | -309,000.00 |
| Sep 30, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 950,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Mar 31, 2025 | -4.58 Mn |
| Mar 31, 2025 | -4.58 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | -1.81 Mn |
| Jun 30, 2024 | -1.81 Mn |
| Mar 31, 2024 | -10.29 Mn |
| Mar 31, 2024 | -10.29 Mn |